Skip to content
GLP-1 Desk
Menu
Dispatch #453

eMed

eMed is a digital health platform best known for at-home diagnostics that now runs a clinician-supported GLP-1 weight management program.

Visit eMedAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Line eMed up against its closest alternatives. Or go one-on-one: eMed vs CoreAge Rx. Because eMed dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency30/100
State access24/100
Molecule range40/100
Onboarding speed66/100
Support responsiveness80/100
Licensing & trust75/100

What the Desk likes

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where points come off

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

The Desk's briefing — C

Best for: Readers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.

eMed ranks #453 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect eMed's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on eMed's site. Not medical advice; see our disclosure.

← Back to The Desk